References
1. Mottillo S., Filion K.B., Genest J., et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta‐analysis. J Am Coll Cardiol. 2010; 56: 1113–32.
2. O’Neill S., O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015; 16: 1–12.
3. Beltrán‐Sánchez H., Harhay M.O., Harhay M.M., McElligott S. Prevalence and trends of metabolic syndrome in the adult US population, 1999–2010. J Am Coll Cardiol. 2013; 62: 697–703.
4. Guembe M.J., Fernandez-Lazaro C.I., Sayon-Orea C., Toledo E., Moreno-Iribas C.; RIVANA Study Investigators. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort. Cardiovasc Diabetol. 2020; 19 (1): 195.
5. Lee E.Y., Han K., Kim D.H., et al. Exposure-weighted scoring for metabolic syndrome and the risk of myocardial infarction and stroke: a nationwide population-based study. Cardiovasc Diabetol. 2020; 19 (1): 153.
6. Gomez-Sanchez L., Garcia-Ortiz L., Patino-Alonso M.C., et al. Association of metabolic syndrome and its components with arterial stiffness in Caucasian subjects of the MARK study: a cross-sectional trial. Cardiovasc Diabetol. 2016; 15 (1): 148.
7. Nilsson P.M. Arterial stiffness, the metabolic syndrome, and the brain. Am J Hypertens. 2017; 31 (1): 24–6.
8. Scuteri A., Najjar S.S., Orru M., et al. The central arterial burden of the metabolic syndrome is similar in men and women: the SardiNIA Study. Eur Heart J. 2010; 31: 602–13.
9. Saklayen M.G. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018; 20 (2): 12.
10. Parfenov A.S. Early diagnosis of cardiovascular diseases using the hardware-software complex «Angioskan-01». Poliklinika [Policlinic]. 2012; (2-1): 70–4. (in Russian)
11. Łoboz-Rudnicka M., Jaroch J., Bociąga Z., et al. Relationship between vascular age and classic cardiovascular risk factors and arterial stiffness. Cardiol J. 2013; 20 (4): 394–401.
12. Koivistoinen T., Lyytikainen L.P., Aatola H., et al. Pulse wave velocity predicts the progression of blood pressure and development of hypertension in young adults. Hypertension. 2018; 71 (3): 451–56.
13. Meani P., Maloberti A., Sormani P., et al. Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3,7 years follow-up. Blood Press. 2018; 27 (1): 32–40.
14. Mattace‐Raso F.U.S, Hofman A., Verwoert G.C., et al. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: «establishing normal and reference values». Eur Heart J. 2010; 31: 2338–50.
15. Tolezani E.C., Costa‐Hong V., Correia G., et al. Determinants of functional and structural properties of large arteries in healthy individuals. Arq Bras Cardiol. 2014; 103: 426–32.
16. Gong J., Xie Q., Han Y., et al. Relationship between components of metabolic syndrome and arterial stiffness in Chinese hypertensives. Clin Exp Hypertens. 2020; 42 (2): 146–52.
17. Weng C., Yuan H., Yang K., et al. Gender‐specific association between the metabolic syndrome and arterial stiffness in 8,300 subjects. Am J Med Sci. 2013; 346 (4): 289–94.
18. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all‐cause mortality with arterial stiffness: a systematic review and meta‐analysis. J Am Coll Cardiol. 2010; 55 (13): 1318–27.
19. Tenenbaum A., Klempfner R., Fisman E.Z. Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor. Cardiovasc Diabetol. 2014; 13: 159.
20. Maloberti A., Vallerio P., Triglione N., et al. Vascular aging and disease of the large vessels: role of inflammation. High Blood Press Cardiovasc Prev. 2019; 26 (3): 175–82.
21. de Oliveira Alvim R., Mourao-Junior C.A., de Oliveira C.M., et al. Glycemic control and arterial stiffness in a Brazilian rural population: Baependi Heart Study. Diabetol Metab Syndr. 2015; 7: 86.
22. Ungvari Z., Kaley G., de Cabo R., et al. Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci. 2010; 65 (10): 1028–41.
23. Thomas G.N., Chook P., Qiao M., et al. Deleterious impact of «high normal» glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arterioscler Thromb Vasc Biol. 2004; 24: 739–43.
24. Shin J.Y., Lee H.R, Lee D.C. Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes. Cardiovasc Diabetol. 2011; 10: 30.
25. Lopes-Vicente W.R.P., Rodrigues S., Cepeda F.X., et al. Arterial stiffness and its association with clustering of metabolic syndrome risk factors. Diabetol Metab Syndr. 2017; 9: 87.